Taguchi, K., Kodama, G., & Fukami, K. WCN24-1846 Linagliptin increases urinary sodium excretion via deactivating renal ENaC in diabetic rodents and patients with diabetes mellites. Elsevier.
Chicago Style (17th ed.) CitationTaguchi, Kensei, Go Kodama, and Kei Fukami. WCN24-1846 Linagliptin Increases Urinary Sodium Excretion via Deactivating Renal ENaC in Diabetic Rodents and Patients with Diabetes Mellites. Elsevier.
MLA (9th ed.) CitationTaguchi, Kensei, et al. WCN24-1846 Linagliptin Increases Urinary Sodium Excretion via Deactivating Renal ENaC in Diabetic Rodents and Patients with Diabetes Mellites. Elsevier.
Warning: These citations may not always be 100% accurate.